Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Akers Biosciences Inc.

TRADE

NASDAQ: AKERHealthcare / Medical Instruments & Supplies / USA
0.36-0.01-2.70%Vol 995 5721Y Perf -68.17%
Jul 20th, 2018 15:59
BID0.36 ASK0.36
Open0.37 Previous Close0.37
Pre-Market0.38 After-Trading0.38
 0.01 2.70%  0.02 5.56%
Target Price
- 
Analyst Rating
— 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)34 
Earnings Rating
Buy
Price Range Ratio 52wk %
14.12 
Earnings Date
13th Aug 2018

Today's Price Range

0.360.38

 

52wk Range

0.121.82

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
-7.69%
3 Months
-34.55%
6 Months
56.52%
1 Year
-68.17%
3 Years
-91.96%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
AKER0.36-0.0100-2.70
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 7.10
Current Ratio 8.10
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -648.40
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin59.10
EBIT Margin-156.60
EBITDA Margin-149.80
Pre-tax Profit Margin-165.10
Profit Margin-83.41
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.95
PS Ratios 14.10
Price to Cash Flow 44.60
Price to Free Cash Flow -11.60
Cash Flow Per Share -0.54
Price to Tangible Book4.67
Book Value per Share0.09
Enterprise Value (in ths.)25 406
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-77.92
ROE last 12 Months -70.83
Return on Assets (5Y Avg) -47.01
ROA last 12 Months -60.93
Return on Capital (5Y Avg) -66.27
ROC last 12 Months -74.12
Return on invested Capital Q -20.20
Return on invested Capital Y-108.24
Assets Turnover0.30
Receivables Turnover3.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)2 064
Revenue per Share 0.03
Revenue Growth 3 Years 8.23
Revenue Growth 5 Years -1.71
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2016--0.19-
Q01 2016--0.28-
Q04 2015--0.69-
Q03 2015--0.36-
Q02 2015--0.41-
Q01 2015--0.26-
Q04 2014--0.19-
Q03 2014--0.23-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date13th Aug 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume995 572
Shares Outstanding (in ths.)94 110
Trades Count861
Dollar Volume358 429
Avg. Volume11 340 648
Avg. Weekly Volume1 878 677
Avg. Monthly Volume2 296 989
Avg. Quarterly Volume4 790 040

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

75%25%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x